Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Pharmaceutics|December 3, 2014
Novel oral phosphate binder with nanocrystalline maghemite-phosphate binding capacity and pH effectT M-H Nguyen, R H Müller, M Taupitz, et al.
International Journal of Pharmaceutics|April 4, 2006
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystalsR H Müller, S Runge, V Ravelli, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisN Schöler, K Krause, O Kayser, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 7, 2007
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporationR H Müller, S A Runge, V Ravelli, et al.
Advanced Drug Delivery Reviews|August 30, 2014
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresR Gref, A Domb, P Quellec, et al.
Die Pharmazie|March 1, 2013
Influence of particle shape on plasma protein adsorption and macrophage uptakeM Jansch, A B Jindal, B Majee Sharmila, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2000
Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infectionK Peters, S Leitzke, J E Diederichs, et al.
Journal of Drug Targeting|May 20, 1998
Surface-modified amikacin-liposomes: organ distribution and interaction with plasma proteinsW E Bucke, S Leitzke, J E Diederichs, et al.
Journal of Pharmaceutical Sciences|April 15, 2011
Preparation and characterization of quercetin nanocrystalsN G Sahoo, M Kakran, L A Shaal, et al.
Pageof 19